Skip to main content
SpringerLink
Log in

Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

In clinical radiology, there are numerous examples of new techniques that were initially enthusiastically promoted and then subsequently abandoned when early promise was not realized in routine patient care. Appropriateness of new or established interventional radiology techniques to specific clinical conditions must be determined from clinical experience, from communication with experts in the field and/or careful review of available medical literature, and on an individual patient basis by means of review of clinical notes and diagnostic imaging studies. For patients with liver neoplasms, regional techniques such as radiofrequency ablation (RFA) have been developed and are now the subject of ongoing research. This article decribes the utilization of Evidence-Based Practice (EBP) techniques as a means of deciding the appropriateness of percutaneous RFA in treating colorectal liver metastases (CLM).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. McKay A, Dixon E, Taylor M (2006) Current role of radiofrequency ablation for the treatment of colorectal liver metastases. Br J Surg 93:1192–1201

    Article  PubMed  CAS  Google Scholar 

  2. Bipat S, van Leeuwen MS, Ijzermans JN, et al. (2007) Evidence-base guideline on management of colorectal liver metastases in the Netherlands. Neth J Med 65:5–14

    PubMed  CAS  Google Scholar 

  3. Staunton M (2007) Evidence-based radiology: steps 1 and 2--asking answerable questions and searching for evidence. Radiology 242:23–31

    PubMed  Google Scholar 

  4. Maher MM, Hodnett PA, Kalra MK (2007) Evidence-based practice in radiology: steps 3 and 4-appraise and apply interventional radiology literature. Radiology 242:658–670

    PubMed  Google Scholar 

  5. Maher MM, McNamara AM, MacEneaney PM, et al. (2003) Abdominal aortic aneurysms: elective endovascular repair versus conventional surgery—evaluation with evidence-based medicine techniques. Radiology 228:647–658

    Article  PubMed  Google Scholar 

  6. Rivoire M (2003) Can initially non-resectable hepatic metastases be made resectable? Gastroenterol Clin Biol 27(Spec No 2):B18-9–B88-104

    Google Scholar 

  7. de Baere T (2003) Modalities and feasibility of treatment by local destruction of hepatic metastases. Gastroenterol Clin Biol 27(Spec No 2):B16-7–B80-7

    Google Scholar 

  8. Elias D (2000) Radiofrequency: storm looming over hepatic surgery. Ann Chir 125(9):815–817

    Article  PubMed  CAS  Google Scholar 

  9. Galandi D, Antes G (2002) Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Cochrane Database Syst Rev (3):CD003046

  10. Ryder SD, British Society of Gastroenterology (2003) Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52(Suppl 3):iii1–iii8

    PubMed  Google Scholar 

  11. Gaiani S, Celli N, Cecilioni L, et al. (2003) Review article: Percutaneous treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2(Suppl 17):103–110

    Article  Google Scholar 

  12. Llovet JM, Fuster J, Bruix J, Barcelona-Clinic Liver Cancer Group (2004) The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 10(2 Suppl 1):S115–S120

    Article  PubMed  Google Scholar 

  13. Galandi D, Antes G (2004) Radiofrequency thermal ablation versus other interventions for hepatocellular carcinoma. Update in Cochrane Database Syst Rev (2):CD003046

  14. Akamatsu M, Yoshida H, Obi S, et al. (2004) Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial. Liver Int 24(6):625–629

    Article  PubMed  Google Scholar 

  15. Lencioni R, Crocetti L (2005) A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis 9(2):301–314, viii

    Article  PubMed  Google Scholar 

  16. Liem MS, Poon RT, Lo CM, et al. (2005) Outcome of transarterial chemoembolization in patients with inoperable hepatocellular carcinoma eligible for radiofrequency ablation. World J Gastroenterol 11(29):4465–4471

    PubMed  Google Scholar 

  17. Santambrogio R, Bianchi P, Palmisano A, et al. (2003) Radiofrequency of hepatocellular carcinoma in patients with liver cirrhosis: a critical appraisal of the laparoscopic approach. J Exp Clin Cancer Res 22(4 Suppl):251–255

    PubMed  CAS  Google Scholar 

  18. Mulier S, Ni Y, Jamart J, et al. (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242(2):158–171

    Article  PubMed  Google Scholar 

  19. Barnes S, Campbell B (2005) Recent NICE guidance of interest to surgeons. Ann R Coll Surg Engl 87(2):136–137

    Article  Google Scholar 

  20. Nguyen MH, Keeffe EB (2005) General management. Best Pract Res Clin Gastroenterol 19(1):161–174

    Article  PubMed  Google Scholar 

  21. Lencioni R, Crocetti L, Cioni D, et al. (2004) Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 39(11):689–697

    Article  PubMed  Google Scholar 

  22. Garden OJ, Rees M, Poston GJ, et al. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55 Suppl 3:iii1–iii8

    Article  PubMed  Google Scholar 

  23. Aloia TA, Vauthey JN, Loyer EM, et al. (2006) Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 141(5):460–466; discussion 466–467

    Article  PubMed  Google Scholar 

  24. Sutherland LM, Williams JA, Padbury RT, et al. (2006) Radiofrequency ablation of liver tumors: a systematic review. Arch Surg 141(2):181–190

    Article  PubMed  Google Scholar 

  25. Decadt B, Siriwardena AK (2004) Radiofrequency ablation of liver tumors: systematic review. Lancet Oncol 5(9):550–560

    Article  PubMed  Google Scholar 

  26. Ng KK, Lam CM, Poon RT, et al. (2003) Thermal ablative therapy for malignant liver tumors: a critical appraisal. J Gastroenterol Hepatol 18(6):616–629

    Article  PubMed  Google Scholar 

  27. Oshowo A, Gillams A, Harrison E, et al. (2003) Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg 90(10):1240–1243

    Article  PubMed  CAS  Google Scholar 

  28. Seidenfeld J, Korn A, Aronson N (2002) Radiofrequency ablation of unresectable liver metastases. J Am Coll Surg 195(3):378–386

    Article  PubMed  Google Scholar 

  29. National Health Service (UK) National Institute for Health and Clinical Excellence (NHS/NICE). Radiofrequency ablation for the treatment of colorectal metastases in the liver. NICE Guidance 2004, http://www.nice.org.uk/IPG092 Accessed May 29, 2007

  30. US National Institutes of Health. National Cancer Institute. Clinical Trials. Phase II randomized study of chemotherapy and Bevacizumab with or without radiofrequency interstitial ablation in patients with unresectable liver metastases secondary to colorectal adenocarcinoma, http://www.cancer.gov/clinicaltrials/EORTC-40004 Accessed May 29, 2007

  31. Haynes RB (2001) Of studies, summaries, synopses and systems: the ‘4S’ evolution of services for finding best current evidence. Evid Based Ment Health 4:37–39

    Article  PubMed  CAS  Google Scholar 

  32. Halligan S, Altman D (2007) Evidence-based practice in radiology: steps 3 and 4—appraise and apply systematic reviews and meta-analyses. Radiology 243(1):13–27

    PubMed  Google Scholar 

  33. Cook RJ, Sackett DL (1995) The number needed to treat: a clinically useful measure of treatment effect. BMJ 310:452–454

    PubMed  CAS  Google Scholar 

  34. MacEneaney PM, Malone DE (2000) Applying ‘evidence-based medicine’ theory to interventional radiology. II. A spreadsheet for swift assessment of procedural benefit and harm. Clin Radiol 55:938–945

    Article  PubMed  CAS  Google Scholar 

  35. Sackett DL, Straus SE, Richardson WS, et al. (2000) Therapy. In: Evidence-based medicine; how to practice and teach EBM, 2nd edn. Philadelphia: Churchill Livingstone, pp 105–110

  36. Solbiati L, Ierace T, Livraghi T, et al. (2001) Outcome and long term survival of patients with liver metastases from colorectal cancer treated with percutaneous cool-tip radiofrequency ablation. Radiology 221:625–626

    Article  Google Scholar 

  37. Gilliams AR, Lees WR (2004) Radiofrequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 14:2261–2267

    Article  Google Scholar 

  38. Solbiati L, Ierace T, Tonoli M, et al. (2001) Radiofrequency thermal ablation of hepatic metastases. Eur J Ultrasound 13:149–158

    Article  PubMed  CAS  Google Scholar 

  39. Gilliams AR, Lees WR (2005) Radiofrequency ablation of colorectal liver metastases. Abdom Imaging 30:419–426

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Radiology, Cork University Hospital, Mercy University Hospital, University College Cork, Cork, Ireland

    Siobhán McGrane, Sean E. McSweeney & Michael. M. Maher

Authors
  1. Siobhán McGrane
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sean E. McSweeney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael. M. Maher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael. M. Maher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGrane, S., McSweeney, S.E. & Maher, M.M. Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic. Abdom Imaging 33, 48–53 (2008). https://doi.org/10.1007/s00261-007-9313-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-007-9313-2

Key words

Search

Navigation